BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12831987)

  • 1. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.
    Langen KJ; Jarosch M; Mühlensiepen H; Hamacher K; Bröer S; Jansen P; Zilles K; Coenen HH
    Nucl Med Biol; 2003 Jul; 30(5):501-8. PubMed ID: 12831987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-Related Uptake of
    Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
    J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
    Spaeth N; Wyss MT; Pahnke J; Biollaz G; Lutz A; Goepfert K; Westera G; Treyer V; Weber B; Buck A
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):673-82. PubMed ID: 16538503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.
    Salber D; Stoffels G; Pauleit D; Oros-Peusquens AM; Shah NJ; Klauth P; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2007 Dec; 48(12):2056-62. PubMed ID: 18006612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of blood-brain barrier permeability on O-(2-
    Stegmayr C; Bandelow U; Oliveira D; Lohmann P; Willuweit A; Filss C; Galldiks N; Lübke JH; Shah NJ; Ermert J; Langen KJ
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):408-416. PubMed ID: 27613541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(18)F-labeled tyrosine derivatives: synthesis and experimental studies on accumulation in tumors and abscesses].
    Fedorova OS; Kuznetsova OF; Shatik SV; Stepanova MA; Belokon' IuN; Maleev VI; Krasikova RN
    Bioorg Khim; 2009; 35(3):334-43. PubMed ID: 19621048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.
    Salber D; Stoffels G; Pauleit D; Reifenberger G; Sabel M; Shah NJ; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2006 Nov; 33(8):1029-35. PubMed ID: 17127177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas.
    Salber D; Stoffels G; Oros-Peusquens AM; Shah NJ; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2010 May; 51(5):790-7. PubMed ID: 20395334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
    Piroth MD; Prasath J; Willuweit A; Stoffels G; Sellhaus B; van Osterhout A; Geisler S; Shah NJ; Eble MJ; Coenen HH; Langen KJ
    Nucl Med Biol; 2013 Aug; 40(6):795-800. PubMed ID: 23769262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
    Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
    J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of iodotyrosines and methionine uptake in a rat glioma model.
    Langen KJ; Clauss RP; Holschbach M; Mühlensiepen H; Kiwit JC; Zilles K; Coenen HH; Müller-Gärtner HW
    J Nucl Med; 1998 Sep; 39(9):1596-9. PubMed ID: 9744350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Bevacizumab on Blood-Brain Barrier Permeability and
    Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ
    J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
    Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
    Stegmayr C; Schöneck M; Oliveira D; Willuweit A; Filss C; Galldiks N; Shah NJ; Coenen HH; Langen KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1115-23. PubMed ID: 26646781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
    Weber WA; Wester HJ; Grosu AL; Herz M; Dzewas B; Feldmann HJ; Molls M; Stöcklin G; Schwaiger M
    Eur J Nucl Med; 2000 May; 27(5):542-9. PubMed ID: 10853810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
    Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.